Volume 19 Issue 9
Sep.  2021
Turn off MathJax
Article Contents
YANG Guang, XU Chen-chen, WANG Jia-wei, DING Ting-ting, LIU Li-jun, LIU Fei-fei, WU Tong, WANG Xun. Study on the correlation between serum homocysteine and blood lipid levels and white matter lesions in patients with Parkinson's disease[J]. Chinese Journal of General Practice, 2021, 19(9): 1451-1454, 1503. doi: 10.16766/j.cnki.issn.1674-4152.002083
Citation: YANG Guang, XU Chen-chen, WANG Jia-wei, DING Ting-ting, LIU Li-jun, LIU Fei-fei, WU Tong, WANG Xun. Study on the correlation between serum homocysteine and blood lipid levels and white matter lesions in patients with Parkinson's disease[J]. Chinese Journal of General Practice, 2021, 19(9): 1451-1454, 1503. doi: 10.16766/j.cnki.issn.1674-4152.002083

Study on the correlation between serum homocysteine and blood lipid levels and white matter lesions in patients with Parkinson's disease

doi: 10.16766/j.cnki.issn.1674-4152.002083
Funds:

 81904086

  • Received Date: 2021-04-05
    Available Online: 2022-02-15
  •   Objective  To find out the risk factors of leukoencephalopathy (WML) in patients with Parkinson's disease (PD) and the correlation between homocysteine levels and WML.   Methods  From January 2015 to January 2020, 200 patients with PD who were hospitalized in the Department of Neurology of the Second Affiliated Hospital of Anhui Medical University were selected as the study group, and 110 patients with healthy physical examination during the same period were selected as the control group. Medical history and demographic data were collected. The level of biochemical indicators in each group were determined. The Fazekas classification was used to divide the study group into four groups. The differences in clinical data and biochemical indicators between the four groups were compared, and logistic regression analysis and Spearman correlation analysis were used to determine the influencing factors of PD patients with WML.   Results  The level of Hcy and the incidence and severity of WML in the study group were higher than those of the control group, and the blood lipid level was lower than that of the control group (all P < 0.05), the Hcy and WML were positively correlated (r=0.556, P < 0.001). After adjusting for demographics and confounding factors, the Hcy level was still positively correlated with the severity of WML (r=0.400, P < 0.001). The AUC of Hcy on WML in PD patients was 0.717 (95% CI: 0.673-0.861, P < 0.001); WML severity was positively correlated with PD patients' HY score and UPDRS exercise score (r=0.460, r=0.360, P < 0.001).   Conclusion  Elevated blood Hcy level may be an independent risk factor for PD patients with WML. Elevated HDL-C level is a protective factor for PD patients with WML. The Hcy may be used as a biomarker for PD patients with WML.

     

  • loading
  • [1]
    [1] LEE Y, KO J, CHOI Y E, et al. Areas of white matter hyperintensities and motor symptoms of Parkinson disease[J]. Neurology, 2020, 95(3): e291-e298. doi: 10.1212/WNL.0000000000009890
    [2]
    KISHI M, WADA-ISOE K, HANAJIMA R, et al. Predictors for incident mild parkinsonian signs in older Japanese[J]. Yonago Acta Med, 2020, 63(1): 1-7. doi: 10.33160/yam.2020.02.001
    [3]
    DUAN J, MUROHARA T, IKEDA H, et al. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia[J]. Arterioscler Thromb Vasc Biol, 2000, 20(12): 2579-2585. doi: 10.1161/01.ATV.20.12.2579
    [4]
    POSTUMA R B, BERG D, STERN M, et al. MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2015, 30(12): 1591-1601. doi: 10.1002/mds.26424
    [5]
    PRINS N D, SCHELTENS P. White matter hyperintensities, cognitive impairment and dementia: An update[J]. Nat Rev Neurol, 2015, 11(3): 157-165. doi: 10.1038/nrneurol.2015.10
    [6]
    VESE L Y ' B, REKTOR I. The contribution of white matter lesions(WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature[J]. Parkinsonism Relat Disord, 2016, 22(Suppl 1): S166-170. http://www.onacademic.com/detail/journal_1000038298273110_1688.html
    [7]
    李静, 童秋玲, 陈为安, 等. 帕金森病患者不同脑区白质疏松与认知功能损害的相关性研究[J]. 中华全科医学, 2020, 18(7): 1083-1085, 1121. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202007006.htm
    [8]
    FAN X, ZHANG L, LI H, et al. Role of homocysteine in the development and progression of Parkinson's disease[J]. Ann Clin Transl Neurol, 2020, 7(11): 2332-2338. doi: 10.1002/acn3.51227
    [9]
    吕晓, 卢晓东. 高同型半胱氨酸血症与帕金森病患者认知功能的相关性分析[J]. 中华全科医学, 2019, 17(1): 83-86. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201901024.htm
    [10]
    KUBO S, HATANO T, HATTORI N. Lipid rafts involvement in the pathogenesis of Parkinson's disease[J]. Front Biosci(Landmark ED), 2015, 20: 263-279. doi: 10.2741/4308
    [11]
    AURIEL E, BORNSTEIN N M, BERENYI E, et al. Clinical, radiological and pathological correlates of leukoaraiosis[J]. Acta Neurol Scand, 2011, 123(1): 41-47. doi: 10.1111/j.1600-0404.2010.01341.x
    [12]
    KLOPPENBORG R P, GEERLINGS M I, VISSEREN F L, et al. Homocysteine and progression of generalized small-vessel disease: The SMART-MR Study[J]. Neurology, 2014, 82(9): 777-783. doi: 10.1212/WNL.0000000000000168
    [13]
    Arslan J, Jamshed H, Qureshi H. Early detection and prevention of Alzheimer's disease: Role of Oxidative markers an0d natural antioxidants[J]. Front Aging Neurosci 2020, 12: 231. doi: 10.3389/fnagi.2020.00231
    [14]
    LE STUNFF H, VéRET J, KASSIS N, et al. Deciphering the link between hyperhomocysteinemia and ceramide metabolism in alzheimer-type neurodegeneration[J]. Front Neurol, 2019, 10: 807. doi: 10.3389/fneur.2019.00807
    [15]
    HUANG G X, LU H, ZHOU Y, et al. Association between Cystatin C and SVD in Chinese population[J]. Neurol Sci, 2018, 39(12): 2197-2202. doi: 10.1007/s10072-018-3577-x
    [16]
    YU X, WANG G, ZHAN J, et al. Risk factors of pure leukoaraiosis and the association with preclinical carotid atherosclerosis[J]. Atherosclerosis, 2018, 275: 328-332. doi: 10.1016/j.atherosclerosis.2018.06.869
    [17]
    FANG E, ANN C N, MARéCHAL B, et al. Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load[J]. J Magn Reson Imaging, 2020, 51(3): 748-756. doi: 10.1002/jmri.26887
    [18]
    DADAR M, GEE M, SHUAIB A, et al. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease[J]. NeuroImage Clin, 2020, 27: 102353. doi: 10.1016/j.nicl.2020.102353
    [19]
    ZHOU X, ZHANG C, LI L, et al. Altered brain function in cerebral small vessel disease patients with gait disorders: A resting-state functional MRI study[J]. Front Aging Neurosci, 2020, 12: 234. doi: 10.3389/fnagi.2020.00234
    [20]
    JIANG S M, WANG M, ZHANG L, et al. Regional homogeneity alterations differentiate between tremor dominant and postural instability gait difficulty subtypes of Parkinson's disease[J]. J Neural Transm(Vienna), 2016, 123(3): 219-229. doi: 10.1007/s00702-015-1490-5
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Article Metrics

    Article views (376) PDF downloads(2) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return